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TECHNICAL NOTE
A PCR method for the quantitative assessment of mRNA for
laminin A, B 1, and B2 chains
SATOSHI H0RIK0sHI,' KATSUNORI FUKUDA,2 PATRIcI0 E. RAY, MAKOTO SAWADA,3
LESLIE A. BRUGGEMAN, and PAUL E. KLOTMAN
Laboratory of Developmental Biology, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland, USA
A PCR method for the quantitative assessment of mRNA for lamimn A,
Bi, and B2 chains. Laminin, a basement membrane glycoprotein, is
involved in the development of normal kidney and its dysregulation
contributes to glomerulosclerosis in renal disease. Studies designed to
assess the regulation of this molecule at the level of transcription have
been hindered by the relatively low abundance of the mRNA, making
standard techniques such as Northern hybridization and RNase protec-
tion difficult and inaccurate. In this report, we have utilized the
polymerase chain reaction (PCR) to quantitate differences in laminin
mRNA expression during normal development of the mouse kidney.
We have constructed a synthetic template to be used as an internal
standard for mRNA quantitation of laminin chains A, Bi and B2, and
/3-actin. This DNA template can be used to generate complementary
RNA which can be reverse transcribed and amplified simultaneously
with 0.5 g of total cellular mRNA allowing for accurate and absolute
quantitation of laminin mRNA by PCR.
Laminin is an extracellular matrix glycoprotein which con-
sists of three polypeptide chains (A, Bi and B2) when isolated
from Engelbreth-Holm-Swarm tumor. Laminin is a normal
constituent of the glomerular basement membrane and renal
mesangium [1]. Laminin has diverse biological activities; it
induces cellular adhesion, differentiation, migration and growth
of many cell types [2, 3] including renal mesangial and epithelial
cells. During nephrogenesis, renal cellular differentiation ap-
pears to depend upon the composition and distribution of
basement membrane components, particularly laminin [4]. In
several animal models of renal disease, abnormal expression of
laminin appears to contribute to the pathogenesis of tubular
interstitial lesions in the case of polycystic kidney disease [5]
and to the pathogenesis of sclerotic lesions and expanded
mesangium as in diabetes [6], puromycin aminonucleoside
nephrosis [7] and lupus nephritis [8]. In humans, the lack of
sufficient biopsy material has limited the study of matrix me-
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tabolism to the appearance of various protein epitopes by
indirect immunofluorescent methods. In order to address the
role of altered gene expression in human renal disease, sensitive
quantitation methods must be devised,
The polymerase chain reaction (PCR) provides a much more
sensitive method of detection, but quantitation is difficult due to
different efficiencies in annealing rates of different primers and
non-linear amplification of target sequences. Therefore, we
have constructed a control template which utilizes the identical
primers as those used for detection of the various laminin chain
mRNAs, and we have determined the linear range of amplifi-
cation so that accurate quantitative comparisons can be made
between samples. The PCR products were easily separated by
polyacrylamide gel electrophoresis and confirmed by sequence
analysis and restriction enzyme digestion of unique sites within
the template.
Methods
Oligonucleotides were synthesized using the 380B DNA
synthesizer (Applied Biosystems, Foster City, California,
USA). Primers [20 base pair (bp) oligomers] were selected to
maximize common sequences between human and mouse for
the three laminin chains and /3-actin. The regions amplified by
each set of primers are as follows (nucleotide numbers are
according to the original reference): laminin A, nucleotides
1201-1527 [9], laminin B1, nucleotides 430-837 [10]; laminin B2,
nucleotides 121-451 [11], 13-actin, nucleotides 172-684 [12].
Each amplified product contained a unique restriction site so
that a specific digestion pattern could be used in place of
sequencing to confirm the accuracy of the amplified sequences.
A DNA template was constructed using an oligonucleotide
overlap extension technique and amplification by PCR as re-
ported by Wang, Doyle and Mark [13]. The synthesized DNA
template was subcloned into the ClaI site of pBlueScript
KS(+/—) (Stratagene, La Jolla, California, USA), and desig-
nated pSH4. This plasmid has T7/T3 promoters immediately
flanking the cloning polylinker such that sense and complemen-
tary RNA (cRNA) can be generated from the template. Tem-
plate cRNA was generated by linearization of pSH4 with ScaI
digestion followed by transcription with T7 RNA polymerase
(Boehringer Mannheim, Indianapolis, Indiana, USA). The
cRNA was digested with DNase I (RNase free) to remove
template DNA from the cRNA preparation. The cRNA was
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Fig. 1. Arrangement and nucleotide sequence
of the control DNA template, pSH4, used for
the quantitation of the laminin genes. A. A
222 bp DNA fragment was constructed
containing a symmetric arrangement of the 5'
and 3' primers used for the amplification of
the three laminin chains and f3-actin mRNA.
B. Nucleotide sequence of pSH4 and
restriction enzyme sites located within the
polylinker. A 5 bp deletion in the 5' primer
222 for laminin B2 occurred during subcloning.
Table 1. Primers for amplification of mouse and human target mRNA
Size of PCR product
mRNA species 5' Primers 3' Primers
(bp)
mRNA Control
Laminin A 5'-AAGTGGCACACGGTCAAGAC-3' 5'-GACAAGAGCTGCATATCCGC-3' 327 166
B! 5'-ATACTFCGCCTATGACTGTG-3' 5 '-CACATGCAGTGTCCGTGAAC-3' 408 166
B2 5'-GAGGAATACTGtTGCAGAC-3' 5'-TCTCGCAGGAACCACTGTAG-3' 331 166
13-act in 5'-GCCCAGAGCAAGAGAGGTAT-3' 5'-GGCCATCTCTFGCTCGAAGT-3' 513 166
Underlined nucleotides indicate divergence between human and mouse sequences. Human sequences are given.
included at the step of the reverse transcriptase (RT) reaction
and thus functions as a control for both the RT and PCR steps.
Kidneys from newborn and three-week-old mice were har-
vested following euthanasia, immediately frozen in liquid nitro-
gen, and total cellular RNA was prepared using the method
described by Chirgwin et al [14]. The final RNA pellets were
resuspended in 50 l of diethylpyrocarbonate-treated (DEPC)
water. For Northern analysis, RNA was fractionated on 0.8%
agarose/formaldehyde gels, transfered to nitrocellulose and
hybridized to a laminin B2 probe as previously described [15].
For PCR analysis, total cellular RNA from kidneys was
converted to cDNA using reverse transcriptase (RT). The RT
mixture contained: 0.5 p.g of total cellular RNA, 500 p.M
dNTPs, 10 units of RNAsin (Promega, Madison, Wisconsin,
USA), 50 pmol of random hexamer (Boehringer Mannheim
Corp.), 25 units of avian myeloblast virus (AMV) reverse
transcriptase (Boehringer Mannheim), 50 mM Tris-HCI (pH
8.0), 50 mivi KCI, 5 mtt MgCl2, 5 mivi DTT, 500 ng bovine serum
albumin in a total volume of 10 p.1. The RT mixture was
incubated at 42°C for 40 minutes, heated at 95°C for 10 minutes,
and then slowly cooled to 24°C. PCR amplification was per-
formed immediately following the RT reaction by adding 5 p.1 of
lOx PCR buffer (100 mrvi Tris-HCI pH 8.3, 500mM KCI, 15 mM
MgCl2, 0.01% gelatin), 500 n of each 5' and 3' primer, 100 nCi
[s- 32PIdCTP and 1 unit of Taq polymerase (Boehringer Mann-
heim), to a total volume of 50 p.1 water. The PCR mixture was
overlaid with mineral oil and then amplified in a thermal cycler
(Coy Laboratory Products, Ann Arbor, Michigan, USA) for 25
cycles. The amplification profile was as follows: denaturation at
94°C for one minute, primer annealing at 55°C for one minute,
and extension at 72°C for two minutes. For laminin B2 chain
amplification, the temperature for primer annealing was re-
duced to 50°C and the temperature for extension was reduced to
60°C. These conditions are suitable for RT/PCR analysis of both
human and mouse mRNA.
Initially, amplified products were confirmed by nucleotide
sequence analysis. Subsequently, the amplified products of the
PCR were analyzed by restriction enzyme digestion followed by
polyacrylamide gel electrophoresis. The PCR sample was ex-
tracted once with phenol/chloroform/isoamyl alcohol (25:24:1),
once with chloroform, and precipitated with 1/10 volume 3 M
sodium acetate and 2 volumes 95% ethanol. The pellet was
resuspended in 50 p.1 of water and 10 p.1 aliquots were digested
with an appropriate restriction enzyme, analyzed by electro-
phoresis on 5% polyacrylamide gels, and the dried gels were
exposed to X-ray film or to one of two phosphorimage analysis
systems; Phosphorimager (Molecular Dynamics, Sunnyvale,
California, USA), or Fujix Bio-Imager BAS2000 (Fuji Photofilm
Inc. Tokyo, Japan). The restriction enzymes used were as
follows: for laminin A, PvuII; for laminin Bl, Scal; for laminin
B2, Dralil; and for /3-actin, BglI.
Results
The arrangement of the control DNA template pSH4 is
shown in Figure 1A, and nucleotide sequence of the insert is
shown in Figure 1 B. The sequences of the primer pairs and
sizes of PCR products are shown in Table 1. A 166 bp fragment
was amplified from the control template for all of the primer
pairs. During the subcloning of the DNA template into pBlue-
Script, 5 nucleotides of the 5' primer for laminin B2 chain were
lost (between nucleotides 7 and 8 in Fig. 1B). The DNA
template was amplified successfully, however, by reducing the
primer annealing temperature to 50°C and the extension tem-
perature to 60°C when using the laminin B2 primers.
Amplification of the control template (undigested plasmid
DNA) was linear in the range of 10 to 300 ng (3 >( IO to 8 x 1010
,Lam B2, Lam Bi ,-actin, Lam A,
A
1Lam B21 Lam Bi, 13-actin1 Lam,
Linker
B
GAGGAATGTG CAGACATACT TCGCCTATGA CTGTGGCCCA GAGCAAGAGA GGCATAAGTG 60
HidIII PStI HincII Bamifi SmaX
V V V V V
GCACACGGTC AAGACG.AATA CAAGCTTCGG CTGCAGGTCG ACTCTAGAGG ATCCCCGGGC 120
E,,QRI
GAGCTCGAAT TCCGGTCTCC CCTACAGTGG TTCCTGCGAG AGTTCACGGA CACTGCATGT 180
GACTTCTGAG CAAGAGATGG CCGCGGATAT GCAGCTCTTG TC
Fig. 2. Linearity of amplification of the
control template. The control DNA template
(undigested plasmid pSH4) was amplified
using the /3-actin primers to demonstrate a
linear response to a range of DNA
concentrations. The amplification of the
control template is linear in a range of 10 ng
to 300 ng. The top panel is a autoradiographic
image of the polyacrylamide gel and the lower
panel is a photograph of the ethidium bromide
staining of the same gel. The graph represents
the quantitation of the radiographic image
using a phosphorimager (Molecular Dynamics)
which calculates the 32P disintegrations (cpm)
in each band.
molecules). Amplification of increasing amounts of pSH4 using
the 13-actin primers is shown in Figure 2. Amplification of the
cRNA from pSH4 was also linear (Fig. 3) in a range from 10 pg
to 0.1 pg (5 x io to 5 x 106 molecules). Under these
conditions, the limit of detection was 5 x iO molecules. Both
ethidium bromide staining and radiographic images of the
polyacrylamide gels of the amplified products were suitable for
quantitation by laser densitometry or phosphorimage analysis.
Figure 4 demonstrates the digestion patterns of a typical
RT/PCR amplification of total cellular mRNA. The amplified
products are designated by an asterisk and the amplified prod-
ucts sizes are compiled in Table 1. Amplified products were
verified by restriction enzyme digestion marked with arrow-
heads. Using the A chain primers, a 327 bp fragment of the
laminin A chain mRNA was amplified and digestion by PvuII
generated 223 bp and 104 bp fragments. Using the BI primers,
a 408 bp fragment of the laminin B 1 chain mRNA was amplified
and digestion by ScaI generated 279 bp and 129 bp fragments.
Using the B2 primers, a 331 bp fragment of the laminin B2 chain
mRNA was amplified and digestion by Dm111 generated 208 bp
and 123 bp fragments. Using the /3-actin primers, a 513 bp
fragment was amplified and digestion with BglI generated 281
bp and 232 bp fragments. The 166 bp fragment amplified from
the control template was also verified for accurate amplification
by digestion with EcoRI which generated 94 bp and 72 bp
fragments. To insure that contaminating genomic DNA had not
been copurified during the preparation of total cellular RNA
each mRNA was amplified in the absence of RT (Fig. 4,
"-RT"). In all samples tested, only the control DNA template,
was amplified, indicating that there was no contamination of
RNA samples with genomic DNA.
Quantitative PCR was compared to standard Northern anal-
ysis by comparing the fall in laminin B2 steady-state rnRNA
levels in kidneys of newborn and three-week-old mice. As
detected by PCR (Fig. 4), the steady-state mRNA levels of the
three chains of laminin in three-week-old mouse kidney de-
creased when compared to newborn mouse kidney. Similarly,
Northern analysis (Fig. 5) also demonstrated a dramatic de-
crease in laminin B2 mRNA to an undetectable level. These
results are in agreement with previous observations of devel-
opmental patterns of laminin expression using various tech-
niques including in situ hybridization [16], immunofluorescence
[17], and Northern analysis U8].
Discussion
PCR is a powerful tool for the detection of specific mRNA
transcripts where standard methods may be limited by the
amount of tissue available (renal biopsy) or by the low abun-
dance of transcripts (adult tissues). The use of quantitative
PCR, however, has been complicated by differences in primer
annealing kinetics and cycle amplification efficiency. Small
differences among primers and variations between samples may
affect the yield of PCR products exponentially, and quantitation
with PCR thus requires an internal standard. For our studies on
laminin gene expression, we have constructed synthetic DNA
and RNA templates to be used as internal standards in PCR
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Fig. 3. Linearity of amplification of
complementaty RNA (cRNA). Serial 1:10
dilution of cRNA from the control template
pSH4 was amplified using the laminin A chain
primers (Lanes 1 through 5). Lane 6 was the
amplification of cRNA without RT. The graph
represents the quantitation of the radioactive
bands using radiographic analysis (Fujix),
where photo-stimUlated luminescence (PSL) is
directly proportional to 32P disintegrations.
The top panel is an autoradiographic image of
the polyacrylamide gel.
1 66—k
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Fig. 4. Amplification of control DNA and total cellular RNA isolated from mouse kidneys. Primers used in each amplification are indicated at the
top of each panel. The band at 166 bp represents the amplification of the control DNA, the bands marked by the asterisk represent the amplification
of target mRNA following reverse transcription (cDNA), and the bands marked by the arrowheads represent the restriction digestion of the
amplified cDNAs. NB, new born mouse RNA; 3W, three week-old mouse RNA; NB, RT-, new born mouse RNA amplified without reverse
transcription. The final lanes represent restriction digests of amplified cDNAs using the enzymes indicated at the top of each lane.
amplification of cDNA and mRNA. This template also provides
a housekeeping gene control. In the construction of this tem-
plate, common sequences were selected between human and
mouse laminin chains and /3-actin such that quantitation would
be possible using both human and mouse RNA.
In this study, we used the control DNA template as an
internal standard in PCR amplification of RNA isolated from
newborn and three-week-old mouse kidney. We detected the
three chains of laminin and f3-actin mRNA and found, as
previously reported, that the steady-state levels of the three
laminin chains decrease during development. At three weeks of
age, Northern analysis barely detects the steady state level of
mRNA for the laminin chains, but the RT/PCR method de-
scribed here easily quantitated laminin mRNA levels using 20
times less RNA. These studies used 0.5 g of total cellular RNA
for RT/PCR analysis, which is much lower than the amount (10
x
-J(I)0
10 10-n 10 10-i 108
cRNA molecules
A B1 B2 -act in /
4.4—
curves would have to be generated using at least three different
concentrations of template. Results should be the same with
each template concentration, assuming amplification is in the
linear range. This will ensure that template interference does
not occur at the concentrations of template and unknown RNA
in each tube. In summary, this RT/PCR method is useful for
both detection and quantitation of laminin mRNA expression
from mouse and human total cellular RNA and is a more
sensitive alternative to Northern analysis. It is our hope that
this template can be used for future studies exploring the role of
laminin transcription in human disease.
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Fig. 5. Northern analysis of total cellular RNA isolated from mouse
kidneys. Ten micrograms of total cellular RNA were fractionated on a
0.8% agarose/formaldehyde gel, transfered to nitrocellulose and hybrid-
ized with a laminin B2 probe. Molecular weight markers are given in
kilobase pairs (Kb), and l8s and 28s RNA are marked with arrows. NB,
newborn mouse; 3 wk, 3-week-old mouse.
gig) required for a successful Northern blot. In addition, the use
of cRNA from pSH4 in both the RT and PCR reactions detected
as little as 5 x io molecules, indicating this PCR protocol may
be useful with a sample size much smaller than 0.5 g of input
RNA. We did not attempt to maximize sensitivity in this study,
but sensitivity would be further enhanced by increasing cycle
number to 40 and/or by altering conditions of the RT and PCR
reactions.
This template can also be used for absolute quantitation of
mRNA molecule number under the following conditions. For
each sample of RNA from human biopsy material, individual
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